
Description
The Biomedical Industry Development Index (CBIB) is directed by the National Development and Reform Commission, and jointly released by China Society of Bioengineering and Flint Creation. It dynamically monitors industrial input, innovation, performance and international influence through a four-level regional index system, covering key provinces, parks and enterprises in China, and provides quantitative basis for policy formulation and industrial analysis.